Cargando…
Current and emerging treatments for uterine myoma – an update
Uterine myomas, the most common benign, solid, pelvic tumors in women, occur in 20%–40% of women in their reproductive years and form the most common indication for hysterectomy. Various factors affect the choice of the best treatment modality for a given patient. Asymptomatic myomas may be managed...
Autor principal: | Duhan, Nirmala |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163653/ https://www.ncbi.nlm.nih.gov/pubmed/21892334 http://dx.doi.org/10.2147/IJWH.S15710 |
Ejemplares similares
-
The Treatment of Uterine Fibro-Myoma
por: Edgar, John
Publicado: (1902) -
Uterine Artery Embolization as Nonsurgical Treatment of Uterine Myomas
por: Tomislav, Strinic, et al.
Publicado: (2011) -
Uterine Artery Occlusion for Treatment of Symptomatic Uterine Myomas
por: Helal, Adel, et al.
Publicado: (2010) -
Epidemiology of Uterine Myomas: A Review
por: Sparic, Radmila, et al.
Publicado: (2016) -
Rare retroperitoneal conditions that mimic uterine myoma
por: Popovici, Răzvan Mihai, et al.
Publicado: (2020)